The Inherited Retinal Disease Trial That Should Change How Sponsors Think About AI Diagnostic Evidence - The Clinical Trial Vanguard
A clinical trial for inherited retinal disease is using AI diagnostic evidence, which could change how sponsors think about AI in trials. The trial's approach may set a new standard for AI-based diagnostic evidence.
- The trial is using AI diagnostic evidence to improve accuracy and efficiency
- The approach could set a new standard for AI-based diagnostic evidence in clinical trials
- The trial's use of AI could lead to better patient outcomes
The inherited retinal disease trial is a significant development in the use of AI in clinical trials.
The trial's use of AI diagnostic evidence could have far-reaching implications for the field of clinical research.
By leveraging AI, the trial aims to improve the accuracy and efficiency of diagnostic evidence, which could lead to better patient outcomes.
The trial's approach may also set a new standard for AI-based diagnostic evidence in clinical trials, which could have a major impact on the development of new treatments and therapies.
It shows how AI can improve healthcare
Artificial intelligence in the exam room - Dakota News Now
AI ResearchPrentis, new AI lab co-founded by Reid Hoffman, Marc Pincus in talks to raise $100M
Put Human Dignity and Democracy at the Center of Artificial Intelligence - People-Powered Progress
New tool identifies the sources of fake video - University of California, Riverside
Weak AI regulations may leave artificial intelligence less safe - Earth.com
Cyberattacks, murder and loss of control: Inside Massachusetts' AI bill - Cape Cod Times
Massachusetts has introduced a bill to regulate AI, focusing on cyberattacks, loss of control, and potential harm. The bill aims to address concerns around AI safety and security.
AI ToolsDatalab Marker v2 vs MinerU, Docling, and Liteparse: Benchmark Breakdown
Datalab's Marker v2 achieves top results in benchmark tests, outperforming MinerU, Docling, and LiteParse in accuracy and speed.
Guillermo del Toro Promises 'Absolutely No Goddamn AI' on 'Pan's Labyrinth' 3D Re-Release - Rolling Stone Australia
Guillermo del Toro has promised not to use AI in the 3D re-release of Pan's Labyrinth. The film director wants to maintain the original's authenticity.
AI ToolsModel Context Protocol Through The Agent Stack Lens: What Broke, What's Fixed July 28, and What to Check Before Your Next mcp.json
Claude Desktop Config and MCP server issues have been addressed in recent updates.
Silicon Valley CEOs take a stand that helps their Chinese rivals - The Washington Post
Silicon Valley CEOs have taken a stance that benefits their Chinese rivals, sparking debate about the implications for the US tech industry.
AI ToolsDatalab’s Marker 2 vs MinerU, Docling and LiteParse: 76.0 on olmOCR-bench at 5× MinerU’s Throughput
Datalab has released Marker 2, an updated OCR pipeline achieving 76.0 on the olmOCR-bench and processing documents five times faster than MinerU on a B200 GPU, also outperforming Docling in both speed and accuracy.